Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $6.2M | $2.0M |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross margin | — | — | — | — | — | — | 0.0% | 0.0% |
| R&D | $27.9M | $41.3M | $59.2M | $50.6M | $46.8M | $55.1M | $83.1M | $145.6M |
| Operating income | −$35.7M | −$60.0M | −$83.0M | −$78.7M | −$74.7M | −$80.9M | −$101.9M | −$177.9M |
| EBITDA | −$35.1M | −$60.0M | −$83.0M | −$78.7M | −$74.7M | −$79.0M | $412.0K | $428.0K |
| Net income | −$35.5M | −$57.5M | −$68.7M | −$69.2M | −$65.6M | −$72.0M | −$85.0M | −$162.3M |
| Net margin | — | — | — | — | — | — | -1362.8% | -7973.3% |
| EPS (diluted) | -1.65 | -59.42 | -1.75 | -1.43 | -1.12 | -23.05 | -21.75 | 0.00 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds MGTA.
No tracked institution reports a position in MGTA as of their last filing.
| Execution date | Ratio |
|---|---|
| 2023-09-12 | 1-for-16reverse |
No one on the platform has traded MGTA yet.
| $45M |
| — |
| LUMOLumos Pharma, Inc. | $4.34 | +0.00% | $38M | — |
| PSTIPluristem Therapeutics Inc. | $1.00 | -2.91% | $41M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.